Spark Therapeutics, Inc. recently announced a public offering issuing two-million primary shares at $47.00 per share. Included in the sale as a secondary offering are one-million shares, at $47.00, held by CHOP.

The Children’s Hospital of Philadelphia has chosen Douglas G. Hock as its new executive vice president and chief operating officer, beginning on Feb. 1.

A $1.5 million grant to CHOP from Alex’s Lemonade Stand Foundation supports an innovative treatment for children with high-risk neuroblastoma.

By any measure, 8-year-old Zion Harvey has led an extraordinary life. At the age of 2, he developed sepsis, a life-threatening infection that led to the amputation of his feet and hands. The illness also damaged his kidneys and, two years later, Zion underwent a kidney transplant — receiving an organ donated by his mother, Pattie Ray.

Spirit Halloween hosted their annual Halloween Party for patients and families at The Children's Hospital of Philadelphia.

The Pulmonary Hypoplasia Program at The Children’s Hospital of Philadelphia is committed to tracking outcomes of children with pulmonary hypoplasia in an effort to improve understanding and care. A recent review of neurodevelopmental outcomes at 5 years of age found that CDH survivors are at increased risk for developing emotionally reactive and pervasive developmental problems.

Neonates with congenital diaphragmatic hernia (CDH) often require intensive treatment after birth and have prolonged hospitalizations, and may suffer a variety of complications after discharge. Comprehensive interdisciplinary follow-up care is critical for long-term well being.

Despite advances in care, there remain high rates of morbidity and mortality in cases of severe CDH. Read about CHOP’s FDA-approved study of fetoscopic endoluminal tracheal occlusion (FETO).

Congenital diaphragmatic hernia (CDH) is a complex and challenging anomaly. Learn about CHOP’s efforts to advance care and improve survival in severely affected children.

A primary care pediatrician in the CHOP Care Network Roxborough practice reflects on addressing the powerful emotions families sometimes display during vaccine conversations.